New York State Common Retirement Fund Moon Lake Immunotherapeutics Transaction History
New York State Common Retirement Fund
- $68.1 Billion
- Q1 2025
A detailed history of New York State Common Retirement Fund transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, New York State Common Retirement Fund holds 6,992 shares of MLTX stock, worth $280,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,992Holding current value
$280,938% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding MLTX
# of Institutions
140Shares Held
58.2MCall Options Held
124KPut Options Held
96.9K-
Bvf Inc San Francisco, CA19.8MShares$794 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$341 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$134 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$111 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$87.9 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.48B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...